AML-derived mutations of FMS-like tyrosine kinase 3 (FLT3) upregulated SUCLG1 to induce POLRMT hyposuccinylation, resulting in enhanced mitobiogenesis and leukemia progression. The gene discussed is POLRMT; the disease is acute myeloid leukemia.